Albireo Pharma, Inc.
(NASDAQ : BIOD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. -2.71%28.4014.1%$167.11m
AMRNAmarin Corp. Plc -2.60%20.221.7%$161.85m
AXSMAxsome Therapeutics, Inc. -2.92%85.201.9%$90.60m
BHCBausch Health Cos., Inc. -2.71%28.400.0%$84.60m
GWPHGW Pharmaceuticals Plc -1.20%114.516.2%$73.62m
JAZZJazz Pharmaceuticals Plc -2.25%145.742.3%$63.95m
PRGOPerrigo Co. Plc -1.24%58.746.8%$63.73m
ICPTIntercept Pharmaceuticals, Inc. -3.02%96.6516.9%$61.51m
SAVACassava Sciences, Inc. -7.18%7.180.0%$60.84m
SAGESAGE Therapeutics, Inc. -3.46%68.028.6%$58.61m
HZNPHorizon Therapeutics Plc -2.83%36.066.6%$56.41m
MNKMallinckrodt Plc -7.68%5.1720.9%$43.68m
ICLRICON plc 0.09%174.954.2%$39.55m
CTLTCatalent, Inc. 0.05%61.602.4%$37.97m
UTHRUnited Therapeutics Corp. -1.70%89.3314.3%$34.80m

Company Profile

Albireo Pharma, Inc. is a pharmaceutical company, which engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its product pipeline includes A4250, Elobixibat, and A3384. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.